Abstract
METHODS: A retrospective data review from a prospectively collected MTP and Trauma registry, at a Level I trauma center, was conducted. All TBI patients who received 10 units PRBC in their 1st 24 hours were included. Patients were divided into two groups: survivors[S] and non-survivors[NS]. Demographic information, clinical characteristics and outcome measures were compared and tested for their association with the crystalloid to blood product ratios administered at 4 and 24 hours post-injury.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
